Pharmaceutical Industry Information Portal


All posts by tag


Biogen invests $120 million in MedRhythms, a music therapy for multiple sclerosis

Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment...

Biogen withdraws application for Alzheimer’s disease drug in Europe

Biogen Inc. has notified the European Medicines Agency (EMA) of its decision to withdraw its Marketing Authorization Application (MAA) for aducanumab for the treatment...

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Samsung Biologics announced that it has reached an agreement with Biogen for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for...

Expert Articles